A detailed history of Asset Management One Co., Ltd. transactions in Eli Lilly & CO stock. As of the latest transaction made, Asset Management One Co., Ltd. holds 358,870 shares of LLY stock, worth $326 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares
358,870
Previous 374,888 4.27%
Holding current value
$326 Million
Previous $292 Million 11.41%
% of portfolio
1.26%
Previous 1.13%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $11.6 Million - $14.6 Million
-16,018 Reduced 4.27%
358,870 $325 Million
Q1 2024

May 02, 2024

SELL
$592.2 - $792.28 $12.5 Million - $16.7 Million
-21,035 Reduced 5.31%
374,888 $292 Million
Q4 2023

Jan 24, 2024

BUY
$525.19 - $619.13 $2.47 Million - $2.91 Million
4,708 Added 1.2%
395,923 $231 Million
Q3 2023

Oct 19, 2023

SELL
$434.7 - $599.3 $1.91 Million - $2.63 Million
-4,389 Reduced 1.11%
391,215 $210 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $1.52 Million - $2.03 Million
4,328 Added 1.11%
395,604 $186 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $3.02 Million - $3.55 Million
9,730 Added 2.55%
391,276 $134 Million
Q4 2022

Feb 06, 2023

SELL
$321.55 - $374.67 $4.95 Million - $5.77 Million
-15,404 Reduced 3.88%
381,546 $140 Million
Q3 2022

Nov 04, 2022

SELL
$296.48 - $337.87 $827,772 - $943,333
-2,792 Reduced 0.7%
396,950 $128 Million
Q2 2022

Jul 29, 2022

SELL
$278.73 - $327.27 $2.86 Million - $3.36 Million
-10,263 Reduced 2.5%
399,742 $130 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $9.25 Million - $11.5 Million
-39,413 Reduced 8.77%
410,005 $117 Million
Q4 2021

Feb 09, 2022

SELL
$224.85 - $279.04 $3.08 Million - $3.82 Million
-13,703 Reduced 2.96%
449,418 $125 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $3.57 Million - $4.39 Million
-16,089 Reduced 3.36%
463,121 $107 Million
Q2 2021

Aug 03, 2021

SELL
$180.55 - $233.54 $6.96 Million - $9 Million
-38,550 Reduced 7.45%
479,210 $110 Million
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $2.36 Million - $3.05 Million
-14,356 Reduced 2.7%
517,760 $96.7 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $2.56 Million - $3.39 Million
19,649 Added 3.83%
532,116 $88.7 Million
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $709,751 - $820,957
-4,854 Reduced 0.94%
512,467 $75.9 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $3.27 Million - $3.94 Million
-23,998 Reduced 4.43%
517,321 $84.9 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $2.1 Million - $2.6 Million
-17,615 Reduced 3.15%
541,319 $75.1 Million
Q4 2019

Feb 14, 2020

SELL
$106.92 - $132.43 $706,313 - $874,832
-6,606 Reduced 1.17%
558,934 $73.5 Million
Q3 2019

Nov 14, 2019

BUY
$106.79 - $116.16 $1.74 Million - $1.89 Million
16,273 Added 2.96%
565,540 $63.2 Million
Q2 2019

Aug 14, 2019

BUY
$110.79 - $129.32 $1.48 Million - $1.73 Million
13,389 Added 2.5%
549,267 $60.9 Million
Q1 2019

May 15, 2019

SELL
$111.31 - $131.02 $126 Million - $149 Million
-1,134,089 Reduced 67.91%
535,878 $69.5 Million
Q4 2018

Feb 13, 2019

SELL
$105.9 - $118.64 $96,157 - $107,725
-908 Reduced 0.05%
1,669,967 $193 Million
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $601,792 - $752,135
-7,009 Reduced 0.42%
1,670,875 $179 Million
Q2 2018

Aug 14, 2018

BUY
$75.7 - $86.88 $1.02 Million - $1.17 Million
13,482 Added 0.81%
1,677,884 $143 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $3.13 Million - $3.7 Million
-42,200 Reduced 2.47%
1,664,402 $129 Million
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $587,755 - $630,434
7,173 Added 0.42%
1,706,602 $144 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $4.94 Million - $5.49 Million
64,146 Added 3.92%
1,699,429 $145 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,635,283
1,635,283 $135 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $864B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Asset Management One Co., Ltd. Portfolio

Follow Asset Management One Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asset Management One Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Asset Management One Co., Ltd. with notifications on news.